Related Experiment Videos
Synergy and other ineffective mixture risk definitions.
Richard C Hertzberg1, Margaret M MacDonell
1US Environmental Protection Agency, National Center for Environmental Assessment, Atlanta, GA, USA. hertzberg.rick@epamail.epa.gov
The Science of the Total Environment
|May 16, 2002
Summary
Traditional labels for chemical interactions (synergistic, antagonistic, additive) offer limited insight into joint toxic action for complex mixtures. Future research in pharmacokinetics and toxicogenomics will enable biologically based models for improved mixture risk assessment.
Area of Science:
- Toxicology
- Environmental Health
- Risk Assessment
Background:
- Established toxicologic labels for chemical interactions (synergism, antagonism, additivity) are primarily defined for binary mixtures.
- These labels offer limited understanding of joint toxic action in real-world exposures involving complex chemical mixtures.
Purpose of the Study:
- To critically evaluate the utility of traditional toxicologic interaction labels.
- To highlight the limitations of current methods in assessing joint toxicity for multi-component exposures.
- To propose future research directions for more accurate mixture risk assessment.
Main Methods:
- Review of existing toxicologic interaction concepts and definitions.
- Analysis of the limitations of pairwise interaction models for complex mixtures.
- Identification of emerging research areas like pharmacokinetics and toxicogenomics.
Main Results:
- Traditional interaction labels are more influential for public perception than for advancing toxicological understanding.
- Current mathematical characterizations of synergism and antagonism are dependent on the definition of 'no interaction', not intrinsic properties.
- Existing methods for quantifying interaction designations in risk assessment are oversimplified and introduce significant uncertainties.
Conclusions:
- Biologically based mathematical models are needed to replace simplistic pairwise interaction labels.
- Advancements in pharmacokinetic measurements/models and toxicogenomics will provide crucial multi-component data.
- Future research should focus on developing these advanced models for improved mixture risk assessment.